ARTICLES BY THIS AUTHOR
- 3/22/2022
Be prepared to assess Ukrainian refugees for infectious disease risks
New guidance document focuses on infection prevention and control issues related to the influx of Ukrainian refugees into other counties. - 3/16/2022
An overview of Covifenz: The first plant-based COVID-19 vaccine approved in Canada
NACI suggests that, like Nuvaxovid, Covifenz may be an option for people unable or unwilling to receive an mRNA COVID-19 vaccine. - 3/14/2022
Patients worried about COVID risk and travel? CATMAT issues guidance statement
Travel may increase the risk of COVID-19, even while following recommended precautions. - 3/9/2022
Long-term cardiovascular risks are substantial in COVID-19 survivors
Survivors of COVID-19 are at increased risk of adverse cardiovascular outcomes even if they were not hospitalized during the acute phase of infection. - 3/8/2022
POP QUIZ: Sexually transmitted infections
Based on the PHAC’s Sexually transmitted and blood-borne infections: Guides for health professionals, all of the following are preferred or alternate treatment regimens for uncomplicated anogenital gonorrhea in adults and youth (≥ 9 years of age), EXCEPT for . . . - 3/7/2022
Effectiveness of COVID-19 vaccines and booster dose against the Omicron variant
Study examines effectiveness after two doses of Pfizer, AstraZeneca or Moderna vaccine and after a booster dose with Pfizer, AstraZeneca or Moderna vaccine. - 3/3/2022
Single-dose Janssen COVID-19 vaccine less effective than two-dose Pfizer vaccine
French study compares effectiveness of Janssen vaccine versus Pfizer vaccine against COVID-19–related hospitalization. - 3/1/2022
Health Canada considering Evusheld for COVID-19 pre-exposure prophylaxis
Single doses of tixagevimab and cilgavimab reduce incidence of symptomatic COVID-19 in at-risk adults for a six-month period. - 2/24/2022
Pop quiz: Trulance for irritable bowel syndrome
All of the following statements about the new drug Trulance (plecanatide tablets) for irritable bowel syndrome are true, EXCEPT for . . . - 2/24/2022
Is combination antidepressant therapy better than antidepressant monotherapy?
Meta-analysis compares combinations of antidepressants with antidepressant monotherapy.